Kene Mamata, Arasu Vignesh A, Mahapatra Ajit K, Huang Jie, Reed Mary E
The Permanente Medical Group, Oakland, California.
Kaiser Foundation Hospital, Department of Emergency Medicine, Fremont, California.
West J Emerg Med. 2021 Apr 2;22(3):614-622. doi: 10.5811/westjem.2021.1.50246.
Acute kidney injury (AKI) after intravenous contrast administration for computed tomography (CT) occurs infrequently, but certain patients may be susceptible. This study evaluated AKI incidence among emergency department (ED) patients with pre-existing chronic kidney disease (CKD) undergoing CT exams.
This retrospective cohort study in an integrated healthcare system included ED patients previously diagnosed with CKD stages 3-5 (estimated glomerular filtration rate <60 milliliters per minute per 1.73 meters squared over at least three months), undergoing CT exams with or without intravenous contrast, from January 1, 2013-December 31, 2017. We excluded patients with CT prior to (30 days) or following (14 days) index CT and missing serum creatinine (sCr) measurements. We applied propensity score matching, and then multivariable regression adjustment for post-CT ED disposition and ED diagnosis, to calculate adjusted risk of AKI. Secondary patient-centered outcomes included 30-day mortality, end-stage renal disease (ESRD) diagnosis, and dialysis initiation.
Among 103,573 eligible ED patients undergoing CT, propensity score matching yielded 5,589 pairs. Adjusted risk ratio (ARR) for AKI was higher overall for contrast-enhanced CT (1.60; 95% confidence interval [CI], 1.43-1.79). However, secondary outcomes were infrequent: 19/5,589 non-contrast vs 40/5,589 contrast patients with new dialysis initiation at 30 days (adjusted risk 0.3% vs 0.7%; adjusted risk reduction 0.4%; 95% CI, 0.1%-0.7%).
In ED patients with chronic kidney disease undergoing CT, intravenous contrast was associated with higher overall adjusted risk of AKI, but patient-centered secondary outcomes were rare. The clinical significance of transient kidney injury after CT is unclear, although patients with advanced chronic kidney disease appear to have elevated risk.
计算机断层扫描(CT)静脉注射造影剂后发生急性肾损伤(AKI)的情况并不常见,但某些患者可能易患。本研究评估了急诊科(ED)中患有慢性肾脏病(CKD)且接受CT检查的患者的AKI发生率。
在一个综合医疗保健系统中进行的这项回顾性队列研究纳入了2013年1月1日至2017年12月31日期间之前被诊断为CKD 3 - 5期(估计肾小球滤过率<60毫升/分钟/1.73平方米,持续至少三个月)且接受了有无静脉造影剂的CT检查的ED患者。我们排除了在索引CT之前(30天)或之后(14天)进行过CT检查以及血清肌酐(sCr)测量缺失的患者。我们应用倾向评分匹配,然后对CT后ED处置和ED诊断进行多变量回归调整,以计算AKI的调整风险。以患者为中心的次要结局包括30天死亡率、终末期肾病(ESRD)诊断和透析开始情况。
在103,573名接受CT检查的符合条件的ED患者中,倾向评分匹配产生了5,589对。总体而言,对比增强CT的AKI调整风险比(ARR)更高(1.60;95%置信区间[CI],1.43 - 1.79)。然而,次要结局并不常见:30天时,19/5,589名未使用对比剂患者与40/5,589名使用对比剂患者开始新的透析(调整风险0.3%对0.7%;调整风险降低0.4%;95%CI,0.1% - 0.7%)。
在接受CT检查的慢性肾脏病ED患者中,静脉注射造影剂与AKI总体调整风险较高相关,但以患者为中心的次要结局很少见。CT后短暂性肾损伤的临床意义尚不清楚,尽管晚期慢性肾脏病患者似乎风险升高。